Related Practice Life Sciences & Pharma This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term. 01262022160113
Published Articles Biotech and Pharmaceuticals EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? December 20, 2023
Executive Insights Life Sciences & Pharma EUnetHTA 21 — Transition to EU-wide HTAs: Implications for Pharma July 31, 2023
Executive Insights Life Sciences & Pharma Navigating the Shifting Landscape in Life Sciences: Trends and Implications July 31, 2023
Executive Insights Diagnostics, Tools and Personalized Medicine Creating a Vibrant Ecosystem for Precision Medicine: A Prescription for Success July 6, 2023
Article Diagnostic & Ancillary Provider & Service Digital Transformation of the Laboratory April 21, 2023